PDF(955 KB)
Expression of mitophagy and apoptosis related genes in peripheral blood mononuclear cells of patients with myasthenia gravis and its clinical diagnosis value
Donghong CAI,Qing LI,Lingling KE,Huiya ZHONG,Qilong JIANG,Han ZHANG,Yafang SONG
PDF(955 KB)
PDF(955 KB)
Expression of mitophagy and apoptosis related genes in peripheral blood mononuclear cells of patients with myasthenia gravis and its clinical diagnosis value
)Objective To discuss the expression levels of mitochondrial autophagy and apoptosis-related genes in peripheral blood mononuclear cells （PBMCs） in the patients with myasthenia gravis （MG），and to clarify its diagnostic value for MG. Methods The PBMCs from 50 healthy controls （control group） and 50 MG patients （MG group） were collected and extracted. Real-time fluorescence quantitative PCR （RT-qPCR） and Western blotting methods were used to detect the expression levels of mitochondrial autophagy factors phosphatase and tensin homolog （PTEN）-induced kinase 1 （PINK1）， E3 ubiquitin-protein ligase PARK2 （Parkin）， ubiquitin-binding protein p62 （p62）， microtubule-associated proteins light chain 3 type Ⅱ （LC3Ⅱ）， and apoptotic factors cytochrome C （Cyt-C）， B cell lymphoma-2 （Bcl-2）， Bcl-2-associated X protein （Bax）， cysteine-containing aspartic acid protease 3 （caspase 3）， and cysteine-containing aspartic acid protease 9 （caspase 9） mRNA and protein. Different cut-off values were set based on the mRNA detection results， and the corresponding sensitivity and specificity at each cut-off value were calculated. The receiver operating characteristic （ROC） curve was drawn. Results Compared with control group， the expression levels of autophagy factors PINK1， Parkin， and LC3Ⅱ mRNA and protein in the PBMCs in MG group were significantly decreased （P<0.01）， while the expression levels of p62 mRNA and protein were increased （P<0.05 or P<0.01）. The expression levels of apoptotic factors Cyt-C， Bax， caspase 3， and caspase 9 mRNA and protein were significantly increased （P<0.05 or P<0.01）， and while the expression levels of Cyt-C mRNA and protein were increased （P<0.05 or P<0.01）， and the expression levels of Bcl-2 mRNA and protein were significantly decreased （P<0.01）. The ROC curve analysis results showed that the area under the curve （AUC） for PINK1， Parkin， p62， and LC3Ⅱ were 0.969 6 （95%CI： 0.943 5-0.995 7）， 0.944 0 （95%CI： 0.904 7-0.983 3）， 0.855 6 （95%CI： 0.776 7-0.934 5）， and 0.908 8 （95%CI： 0.852 6-0.965 0） （P<0.01）， respectively，and the sensitivities were 92%， 92%， 78%， and 84%， and the specificities were 88%， 82%， 92%， and 82%， respectively； whereas the AUC for Cyt-C， Bax， Bcl-2， caspase 3， and caspase 9 was 1.000 （P<0.01）， and the sensitivity and specificity reached 100%. Conclusion Mitochondrial autophagy disorder and increased apoptosis are found in the PBMCs in the patients with MG， which has a higher guiding value for clinical diagnosis of MG.
Myasthenia gravis / Mitophagy / Apoptosis / Peripheral blood mononuclear cell / Diagnostic value
R746.1
| 1 | 常 婷. 中国重症肌无力诊断和治疗指南（2020版）［J］. 中国神经免疫学和神经病学杂志，2021，28（1）：1-12. |
| 2 | PUNGA ANNA ROSTEDT， MADDISON PAUL， HECKMANN HEANNINE M，et al.Epidemiology， diagnostics， and biomarkers of autoimmune neuromuscular junction disorders［J］. Lancet Neurol，2022，21（2）：176-188. |
| 3 | HUIJBERS M G， MARX A， PLOMP J J， et al. Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders［J］. Lancet Neurol， 2022， 21（2）： 163-175. |
| 4 | LI L Q， CAI D H， ZHONG H Y， et al. Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis［J］. Exp Ther Med， 2022， 23（4）： 307. |
| 5 | JIAO W， HU F Y， LI J Q， et al. Qiangji Jianli Decoction promotes mitochondrial biogenesis in skeletal muscle of myasthenia gravis rats via AMPK/PGC-1α signaling pathway［J］. Biomed Pharmacother， 2020， 129： 110482. |
| 6 | 沈 洁， 臧海生， 徐蓓峥， 等.重症肌无力的中西医治疗进展［J］. 现代中西医结合杂志， 2021， 30（36）： 4089-4094. |
| 7 | 岳冬曰. 重症肌无力患者线粒体损害的初步研究［D］. 上海： 复旦大学， 2012. |
| 8 | TANG J Q， YE Z M， LIU Y， et al. Autophagy-deficiency in bone marrow mononuclear cells from patients with myasthenia gravis： a possible mechanism of pathogenesis［J］. Int J Neurosci， 2021，131（3）： 239-253. |
| 9 | LEMASTERS J J. Selective mitochondrial autophagy， or mitophagy， as a targeted defense against oxidative stress， mitochondrial dysfunction， and aging［J］. Rejuvenation Res， 2005， 8（1）： 3-5. |
| 10 | HUANG S Y， WANG X N， YU J L， et al. LonP1 regulates mitochondrial network remodeling through the PINK1/Parkin pathway during myoblast differentiation［J］. Am J Physiol Cell Physiol， 2020， 319（6）： C1020-C1028. |
| 11 | LIZAMA B N， CHU C T. Neuronal autophagy and mitophagy in Parkinson’s disease［J］. Mol Aspects Med， 2021， 82： 100972. |
| 12 | MUCHA O， KAZIRóD K， PODKALICKA P， et al. Dysregulated autophagy and mitophagy in a mouse model of Duchenne muscular dystrophy remain unchanged following heme oxygenase-1 knockout［J］. Int J Mol Sci， 2021， 23（1）： 470. |
| 13 | SEABRIGHT A P， LAI Y C. Regulatory roles of PINK1-parkin and AMPK in ubiquitin-dependent skeletal muscle mitophagy［J］. Front Physiol， 2020， 11： 608474. |
| 14 | SMITH E F， SHAW P J， DE VOS K J. The role of mitochondria in amyotrophic lateral sclerosis［J］. Neurosci Lett， 2019， 710： 132933. |
| 15 | WANG N， YUAN J， KARIM M R， et al. Effects of mitophagy on regulatory T cell function in patients with myasthenia gravis［J］. Front Neurol， 2020， 11： 238. |
| 16 | 贡 歌， 杨 翔， 殷 建， 等. 自噬和凋亡在肌少症中的研究进展［J］.中国医学科学院学报，2018，40（1）： 112-115. |
| 17 | SUN Y H， SU Q， LI L， et al. miR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway［J］. BMC Cardiovasc Disord， 2017， 17（1）： 119. |
| 18 | OBENG E. Apoptosis （programmed cell death） and its signals-A review［J］.Rev Brasleira De Biol，2021，81（4）： 1133-1143. |
| 19 | RAHMAN F A， QUADRILATERO J. Mitochondrial apoptotic signaling involvement in remodeling during myogenesis and skeletal muscle atrophy［J］. Semin Cell Dev Biol， 2023， 143： 66-74. |
| 20 | 李 艳， 何前松， 况时祥，等. HPA轴损伤对实验性重症肌无力大鼠易感性的影响［J］. 中国中医基础医学杂志， 2019， 25（1）： 63-67. |
| 21 | CHEN W， CHEN Y S， LIU Y X， et al. Autophagy in muscle regeneration： potential therapies for myopathies［J］. J Cachexia Sarcopenia Muscle， 2022， 13（3）： 1673-1685. |
| 22 | AVRUTSKY M I， TROY C M. Caspase-9： a multimodal therapeutic target with diverse cellular expression in human disease［J］. Front Pharmacol， 2021， 12： 701301. |
/
| 〈 |
|
〉 |
AI Summary
